Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) reported Total Debt of $106508.0 for Q4 2025, up 6.26% quarter-over-quarter from $100230.1 in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) has reported Total Debt for 2 years, with the latest figure at $106508.0 in Q4 2025.

For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $106508.0; the trailing twelve-month figure through Oct 2025 stood at $106508.0 (changed N/A YoY), and the FY2025 full-year result was $100321.9, down 76.48% from the prior year.
Total Debt for Q4 2025 stood at $106508.0, up from $100230.1 in the prior quarter.
The five-year high for Total Debt was $426507.1 in Q2 2024, with the low at $100230.1 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Total Debt (Qtr)
1	Abbott Laboratories	154.42 Bn	147.76 Bn	6.27 Bn	34.05 Bn
2	Stryker	118.12 Bn	115.25 Bn	3.81 Bn	14.72 Bn
3	Medtronic	101.72 Bn	93.55 Bn	5.76 Bn	28.07 Bn
4	Boston Scientific	67.19 Bn	65.98 Bn	3.61 Bn	11.03 Bn
5	Edwards Lifesciences	50.69 Bn	47.02 Bn	1.29 Bn	598.50 Mn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	9.48 Bn
7	Dexcom	28.09 Bn	26.97 Bn	750.30 Mn	-
8	GE HealthCare Technologies	28.08 Bn	26.02 Bn	1.98 Bn	10.13 Bn
9	Steris	19.80 Bn	19.37 Bn	697.10 Mn	1.93 Bn
10	Phaos Technology Holdings (Cayman)	682,234.12	627,245.12	-	106,508.00

Download Data